Initial clinical trial of a closed loop, fully automatic intra-aortic balloon pump

Area of Science:

• Cardiovascular Engineering
• Medical Devices
• Critical Care Medicine

Background:

• Intraaortic balloon pumps (IABP) are crucial for hemodynamic support.
• Current IABP systems require manual adjustments, limiting optimal performance.
• A need exists for automated IABP systems for improved patient outcomes.

Purpose of the Study:

• To evaluate the safety and efficacy of a new closed-loop, fully automatic intraaortic balloon pump (CL-IABP) system.
• To assess the system's ability to optimize diastolic augmentation in real-time.
• To determine the feasibility of clinical application for the CL-IABP.

Main Methods:

• The CL-IABP system was tested in dogs and subsequently in 10 human patients requiring IABP support.
• System performance was evaluated based on parameter optimization time, inflation/deflation timing, and peak pressure.
• Patient outcomes and adverse events were monitored during an average of 20 hours of support.

Main Results:

• The CL-IABP system optimized parameters within 7-20 seconds and achieved 99% inflation timing accuracy relative to the dicrotic notch.
• Deflation occurred within the first half of ventricular ejection in 100% of recordings, with safe peak pressures.
• Eight out of ten patients showed clinical improvement, with no complications attributed to the automated system.

Conclusions:

• A fully automated, closed-loop IABP system is feasible for clinical use.
• The CL-IABP system provides safe, effective, and consistent diastolic augmentation without operator intervention.
• This technology may offer significant advantages compared to conventional IABP systems.